C
Krystal Biotech, Inc. KRYS
$183.92 $1.170.64%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024
Revenue 8.70% 19.29%
Total Other Revenue -- --
Total Revenue 8.70% 19.29%
Cost of Revenue -25.96% 11.23%
Gross Profit 11.71% 20.04%
SG&A Expenses 8.97% 3.93%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses 1.74% -0.63%
Operating Income 18.45% 65.83%
Income Before Tax 63.29% 85.53%
Income Tax Expenses 20.93% 442.77%
Earnings from Continuing Operations 67.33% 74.59%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 67.33% 74.59%
EBIT 18.45% 65.83%
EBITDA 18.06% 57.70%
EPS Basic 67.10% 73.86%
Normalized Basic EPS 14.85% 47.48%
EPS Diluted 67.71% 71.70%
Normalized Diluted EPS 15.08% 46.76%
Average Basic Shares Outstanding 0.14% 0.41%
Average Diluted Shares Outstanding -0.06% 0.89%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings